BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB AND Prognosis
744 results:

  • 1. Near-infrared imaging of head and neck squamous cell carcinoma using indocyanine green that targets the
    Yuan Y; Fan T; Wang J; Yuan Y; Tao X
    J Biomed Opt; 2024 Apr; 29(4):046002. PubMed ID: 38633382
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Evaluation of Some Prognostic Biomarkers in Human Papillomavirus-Related Multiphenotypic Sinonasal Carcinoma.
    Alabiad MA; Said WMM; Adim AMA; Alorini M; Shalaby AM; Samy W; Elshorbagy S; Mandour D; Saber IM; Yahia AIO; Khairy DA
    Iran J Med Sci; 2024 Mar; 49(3):156-166. PubMed ID: 38584650
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [History and Perspective of Chemotherapy in Advanced Esophageal cancer].
    Shiraishi K; Kato K
    Gan To Kagaku Ryoho; 2024 Mar; 51(3):240-244. PubMed ID: 38494800
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Molecular and nutritional markers in head and neck cancer.
    Milano G; Gal J; Bensadoun RJ
    Curr Opin Oncol; 2024 May; 36(3):123-127. PubMed ID: 38441194
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Expression of egfr and p16 in Squamous Cell Carcinoma of External Auditory Canal.
    Kajimoto Y; Shinomiya H; Uehara N; Teshima M; Fujita T; Kakigi A; Imamura Y; Kiyota N; Miyawaki D; Sasaki R; Kimura H; Nibu KI
    Kobe J Med Sci; 2024 Jan; 69(4):E144-E150. PubMed ID: 38379276
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Study of the association of the known prognostic variables with egfr expression in head and neck squamous cell carcinomas.
    Jadhav T; Malik A; Kashif AW; Shelly D; Mishra PS; Baranwal AK; Sahu R
    Indian J Pathol Microbiol; 2024; 67(1):36-45. PubMed ID: 38358186
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinical impact of proteinuria on renal function and treatment outcomes in patients with radioiodine-refractory thyroid cancer treated with lenvatinib.
    Fukuda N; Toda K; Suto H; Oki R; Wang X; Urasaki T; Sato Y; Nakano K; Ono M; Tomomatsu J; Mitani H; Takahashi S
    Endocr J; 2024 Apr; 71(4):363-371. PubMed ID: 38296547
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. CCDC86 promotes the aggressive behavior of nasopharyngeal carcinoma by positively regulating egfr and activating the PI3K/Akt signaling.
    Wang Z; Zhou T; Chen X; Zhu X; Liao B; Liu J; Li S; Tan T; Liu Y
    Neoplasma; 2023 Dec; 70(6):761-776. PubMed ID: 38247332
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Deep learning-radiomics integrated noninvasive detection of epidermal growth factor receptor mutations in non-small cell lung cancer patients.
    Kim S; Lim JH; Kim CH; Roh J; You S; Choi JS; Lim JH; Kim L; Chang JW; Park D; Lee MW; Kim S; Heo J
    Sci Rep; 2024 Jan; 14(1):922. PubMed ID: 38195717
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Unveiling Therapeutic Targets for Esophageal cancer: A Comprehensive Review.
    Acharya R; Mahapatra A; Verma HK; Bhaskar LVKS
    Curr Oncol; 2023 Oct; 30(11):9542-9568. PubMed ID: 37999111
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Decoding the role of miRNAs in oral cancer pathogenesis: A focus on signaling pathways.
    Doghish AS; El-Husseiny AA; Khidr EG; Elrebehy MA; Elballal MS; Abdel-Reheim MA; Abdel Mageed SS; Zaki MB; Mohammed OA; Khaled R; El-Dakroury WA; Noureldin S; Moustafa YM; Mangoura SA; Gedawy EM; Abulsoud AI
    Pathol Res Pract; 2023 Dec; 252():154949. PubMed ID: 37992507
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Nasopharyngeal carcinoma with non-squamous phenotype may be a variant of nasopharyngeal squamous cell carcinoma after inhibition of egfr/PI3K/AKT/mTOR pathway.
    Wang J; Shang Y; Wang Y; Li Y; Wang L; Huang S; Lyu X
    Histol Histopathol; 2024 May; 39(5):647-657. PubMed ID: 37971211
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Identify and validate circadian regulators as potential prognostic markers and immune infiltrates in head and neck squamous cell carcinoma.
    Jin Y; Wang Z; Huang S; Liu C; Wu X; Wang H
    Sci Rep; 2023 Nov; 13(1):19939. PubMed ID: 37968308
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Radiotherapy Plus Cisplatin With or Without Lapatinib for Non-Human Papillomavirus head and neck Carcinoma: A Phase 2 Randomized Clinical Trial.
    Wong SJ; Torres-Saavedra PA; Saba NF; Shenouda G; Bumpous JM; Wallace RE; Chung CH; El-Naggar AK; Gwede CK; Burtness B; Tennant PA; Dunlap NE; Redman R; Stokes WA; Rudra S; Mell LK; Sacco AG; Spencer SA; Nabell L; Yao M; Cury FL; Mitchell DL; Jones CU; Firat S; Contessa JN; Galloway T; Currey A; Harris J; Curran WJ; Le QT
    JAMA Oncol; 2023 Nov; 9(11):1565-1573. PubMed ID: 37768670
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Overexpression of RAB27A in Oral Squamous Cell Carcinoma Promotes Tumor Migration and Invasion via Modulation of egfr Membrane Stability.
    Huang J; Yang JG; Ren JG; Xia HF; Chen GH; Fu QY; Zhang LZ; Liu HM; Wang KM; Xie QH; Chen G
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685910
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Analysis of myosin genes in HNSCC and identify MYL1 as a specific poor prognostic biomarker, promotes tumor metastasis and correlates with tumor immune infiltration in HNSCC.
    Li C; Guan R; Li W; Wei D; Cao S; Chang F; Wei Q; Wei R; Chen L; Xu C; Wu K; Lei D
    BMC Cancer; 2023 Sep; 23(1):840. PubMed ID: 37679666
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A novel and independent survival prognostic model for OSCC: the functions and prognostic values of RNA-binding proteins.
    Wang S; Liu S; Zhu Y; Zhang B; Yang Y; Li L; Sun Y; Zhang L; Fan L; Hu X; Huang C
    Eur Arch Otorhinolaryngol; 2024 Jan; 281(1):397-409. PubMed ID: 37656222
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Expression and prognostic value of AIM1L in esophageal squamous cell carcinoma.
    Zhou L; Gan L; Liu Z
    Medicine (Baltimore); 2023 Aug; 102(34):e34677. PubMed ID: 37653730
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Anti-PD1 rechallenge in combination with anti-angiogenesis or anti-egfr treatment beyond progression in recurrent/metastatic nasopharyngeal carcinoma patients.
    Jiang Y; Fang T; Lu N; Bei W; Dong S; Xia W; Liang H; Xiang Y
    Crit Rev Oncol Hematol; 2023 Oct; 190():104113. PubMed ID: 37633346
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Efficacy of non-surgical comprehensive treatment for locally advanced hypopharyngeal carcinoma with cervical esophagus invasion].
    Geng ZY; Chen NX; You W; Liu K; Gu X; Wei J; Ma L; Zhang XX
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Aug; 58(8):773-780. PubMed ID: 37599238
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 38.